AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Sacubitril Valsartan Sodium Hydrate in South Africa
6 products registered with SAHPRA — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ENTRESTO 50 mg | 50/7.6/1016 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| ENTRESTO 100 mg | 50/7.6/1017 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| ENTRESTO 200 mg | 50/7.6/1018 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| VYMADA 50 mg | 50/7.6/1019 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| VYMADA 100 mg | 50/7.6/1020 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| VYMADA 200 mg | 50/7.6/1021 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
Sacubitril Valsartan Sodium Hydrate — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Sacubitril Valsartan Sodium Hydrate, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Sacubitril Valsartan Sodium Hydrate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.